Deferasirox Tablets

Product/Composition:- Deferasirox Tablets
Strength:- 100mg, 250mg, 400mg
Form:- Tablets
Production Capacity 10 Million Tablets/Month
Packaging:- 1 X 10 Tablets / Box
Therapeutic use:- Anti Cancer
Package Insert/Leaflet: Available upon request

Description

The following is a list of possible side-effects that may occur in medicines that contain Deferasirox. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.Indigestion, Protein In The Urine, Vomiting, Bloating, Pain In The Stomach, Difficulty In Passing Stool.

Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below. Always take it on an empty stomach by dissolving into a glass of water, Avoid taking it, if you are pregnant, planning to become pregnant or are breastfeeding, Do not chew, crush, break or swallow the tablets as a whole, It may cause dizziness.

If you use other drugs or over the counter products at the same time, the effects of Deferasirox may change. This may increase your risk for side-effects or cause your drug not to work properly. Tell your doctor about all the drugs, vitamins, and herbal supplements you are using, so that you doctor can help you prevent or manage drug interactions. Deferasirox may interact with the following drugs and products like Allopurinol, Alprazolam, Atorvastatin, Cholecalciferol, Cyanocobalamin, Esomeprazole.